Related Experiment Video

Updated: Jul 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Treatment and course of community-acquired pneumonia caused by atypical pathogens]

Ramón Fernández Alvarez1, Isabel Suárez Toste, Gemma Rubinos Cuadrado

  • 1Servicio de Neumología, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, España. enelllano@terra.es

Archivos De Bronconeumologia
|October 17, 2006
PubMed
Abstract

Insights

Empiric antibiotic treatment targeting atypical pathogens like Mycoplasma pneumoniae did not significantly alter outcomes for community-acquired pneumonia patients. This study found no improvement in clinical or radiographic recovery with such targeted antibiotic regimens.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) can be caused by atypical pathogens, including Mycoplasma pneumoniae, Legionella species, Coxiella burnetii, and Chlamydophila pneumoniae.
  • Empiric antibiotic selection is crucial for CAP management, but the benefit of specifically targeting atypical pathogens requires further investigation.

Purpose of the Study:

  • To evaluate the clinical course and outcomes of patients hospitalized with CAP caused by atypical pathogens.
  • To compare outcomes based on whether empiric antibiotic treatment covered atypical pathogens.

Main Methods:

  • Retrospective analysis of 89 patients with atypical pathogen CAP admitted between 1996 and 2001.
  • Patients were divided into two groups: Group A received antibiotics covering atypical pathogens (quinolones or macrolides), while Group B received non-covering treatment.
  • Outcomes assessed included length of hospital stay, radiographic resolution, 30-day readmission rates, and mortality.

Main Results:

  • No significant differences were observed between Group A (39 patients) and Group B (50 patients) in length of hospital stay, radiographic resolution, readmission rates, or mortality.
  • The study included 89 patients diagnosed with pneumonia caused by atypical pathogens.

Conclusions:

  • Empiric antibiotic regimens that provide coverage for atypical pathogens did not demonstrate improved clinical or radiographic outcomes in hospitalized CAP patients.
  • Current empiric treatment strategies for CAP may not necessitate specific coverage for atypical pathogens based on these findings.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.